Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name BIOVIE INC Proposed Ticker BIVI CUSIP 09074F207 Business Description A clinical-stage company pursuing the discovery, development, and commercialization of innovative drug therapies. Lead Underwriter ThinkEquity, a division of Fordham Financial Management, Inc Co-Managers N/A Initial Shares 12,62,626 Revised Initial Shares 13,11,189 Initial Price $11.88-$11.88 Revised Price $11.44-$11.44 Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.